CORREVIO PHARMA CORP ORDINARY SHARES (CORV) SEC filings
CORV SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CORV overview →
No CORV SEC filing events in the measured window.
Nothing matched in the current window — the CORV overview has every event we measure for this name.
Get an email when CORV moves on news →Keep exploring
More CORV: earnings → · analyst actions → · CORV overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rigel Pharmaceuticals, Inc. (RIGL) | 281 | -0.46% | 42% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 279 | -0.52% | 36% |
| Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF) | 278 | -0.48% | 36% |
| AtriCure, Inc. (ATRC) | 276 | +0.04% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.